Back to HHLR Advisors, Ltd. HHLR Advisors, Ltd.

TNGX

4 quarters

Position history for HHLR Advisors, Ltd.HHLR Advisors, Ltd.'s holdings in Tango Therapeutics, Inc.

No. HHLR Advisors exited its TNGX (Tango Therapeutics) position in Q2 2022. Its Q1 2022 13F listed 882,088 shares worth $6.7M. HHLR Advisors already held TNGX in its Q3 2021 13F, the earliest on record, and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$56.6M

Total Shares Change

-4.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q2
Latest
Exited
0
-100.0%
$00.0%$4.32
0
2022-Q1
Decreased
882,088
-77.2%
$6.7M0.1%$7.75
0
2021-Q4
Decreased
3.9M
-11.4%
$42.4M0.7%$10.86
0
2021-Q3
New
4.4M
-
$56.6M0.7%$12.03
57

Other major holders of TNGX: RTW Investments, LP, BlackRock, Inc., FMR LLC, Farallon Capital Management, L.L.C., Goldman Sachs Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used